ArticlePLOS digital health2026
Deep-learning time-series anomaly detection of acute kidney injury from creatinine-eGFR trajectories in the ICU.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury (AKI) is common in the intensive care unit (ICU), and fixed creatinine thresholds may miss clinically relevant dynamics. We tested whether a deep-learning anomaly signal from short creatinine-estimated glomerular filtration rate (eGFR) series complements conventional criteria for risk stratification. Seven-step daily creatinine-eGFR instances were built from the Medical Information Mart for Intensive Care (MIMIC-III/IV; development/internal validation) and the eICU Collaborative Research Database (external validation). Time series began within 48 hours before ICU admission and ended at kidney replacement therapy (KRT), death, or ICU discharge. An unsupervised Anomaly Transformer trained on MIMIC produced final-step anomaly scores; the 95th percentile of training scores defined a fixed threshold. Anomaly-detected AKI required a final-step creatinine rise plus a score ≥ threshold. We compared scores across Kidney Disease: Improving Global Outcomes (KDIGO) stages and evaluated 24-96-hour KRT and mortality using area under the receiver operating characteristic curve (AUROC), accuracy, and F1-score. After exclusions, the internal dataset included 81,876 admissions (381,700 time-series instances) and the external dataset 140,237 admissions (494,684 instances). Anomaly scores increased stepwise across KDIGO categories and were higher in windows followed by KRT or death. For KRT prediction at 24, 48, 72, and 96 hours, AUROCs were 0.83, 0.82, 0.81, and 0.80 internally and 0.74 at all horizons externally. For mortality, AUROCs were 0.64-0.66 internally and 0.62-0.64 externally. In threshold-based classification, F1-scores were generally highest with the anomaly rule alone, whereas accuracy was greatest when requiring both anomaly detection and KDIGO stage ≥2. Event-capture analyses showed that anomaly detection identified more near-term KRT and mortality events than KDIGO stage ≥2, with the clearest separation for KRT. A creatinine-eGFR trajectory-based anomaly signal aligned with clinical severity, was associated with near-term outcomes, and appeared to complement KDIGO-based criteria in ICU populations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.